2023-10-05 14:50:00 2023-10-07 14:40:00 Europe/Madrid 12º Actualización en el Tratamiento de la Leucemia Aguda 12º Actualización en el Tratamiento de la Leucemia Aguda Auditorio Fundación MD Anderson Cancer Center España - C. de Gómez Hemans, 2, 28033 Madrid cursoleucemia@doctaforum.com

Jueves, 5 de Octubre


14:50 – 15:00        Welcome

15:00 – 16:00        MEET THE EXPERT 1 Key points in the treatment of Polycythaemia Vera. Interactive clinical case study

Dr. Valentín García Gutiérrez, Hospital Universitario Ramón y Cajal, Madrid, Spain

16:00 – 16:55       SESSION 1 LMA 2 Target therapies – I

Chairs:
Dr. Naval Daver, MD Anderson Cancer Center, Houston, USA
Dr. Adolfo de la Fuente, MD Anderson Cancer Center Madrid, Spain
16:00 - 16:20Targeting IDH 1
Dr. Courtney DiNardo, MD Anderson Cancer Center, Houston, USA
16:20 - 16:40FLT 3 inhibitors in relapse setting, biomarkers and mechanism of resistance
Dr. Naval Daver, MD Anderson Cancer Center, Houston, USA
16:40 - 16:55Discussion

16:55 – 17:50       SESSION 2 ALL session

Chairs:
Dr. Elias Jabbour, MD Anderson Cancer Center, Houston, USA
Dr. Adolfo de la Fuente, MD Anderson Cancer Center Madrid, Spain
Dr. Alessandro Isidori, Marche Nord Hospital, Pesaro, Italy
16:55 - 17:15Ph-positive, ready for Chemo-free approach
Dr. Elias Jabbour, MD Anderson Cancer Center, Houston, USA
17:15 - 17:35Management of the elderly patient of ALL
Dr. María Calbacho, Hospital Universitario 12 de Octubre, Madrid, Spain
17:35 - 17:50Discussion

17:50 – 18:10       Coffe Break

18:10 – 19:25       SESSION 3 Diagnosis and preclinical management of leukaemia

Chairs:
Dr. Joaquín Sánchez, Hospital Universitario Reina Sofía, Córdoba, Spain
Dr. Adolfo de la Fuente, MD Anderson Cancer Center Madrid, Spain
18:10 - 18:30ELN-2022 risk stratification and the challenge of working with two AML classifications
Dr. Jordi Sierra, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
18:30 - 18:50MRD determination and treatment algorithms
Dr. Eva Barragán, Hospital Universitario y Politécnico La Fe, Valencia, Spain
18:50 - 19:10Ex-Vivo tridimensional models for drug-sensitivity studies in AML
Dr. Juana Serrano, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain
19:10 - 19:25Discussion

19:25 – 20:25       DISCUSSION Induction therapy in transplant candidates. Intensive chemotherapy versus venetoclax-based therapy

Chairs:
Dr. Mar Tormo, Hospital Clínico Universitario de Valencia, Spain
Dr. Ángela Figuera, Hospital Universitario de La Princesa, Madrid, Spain
Dr. Adolfo de la Fuente, MD Anderson Cancer Center Madrid, Spain
Dr. Guillermo García-Manero, MD Anderson Cancer Center, Houston, USA
Transplant candidate patient Intensive Induction
YES - Dr. Josefina Serrano, Hospital Universitario Reina Sofía, Córdoba, Spain
NO - Dr. Jordi Esteve, Hospital Clínic de Barcelona, Spain
Discussion